Other languages MediWound Ltd.

Equities

MDWD

IL0011316309

Market Closed - Nasdaq Other stock markets 16:00:00 2024-04-30 EDT			5-day change	1st Jan Change
18.61 ^USD	-3.17%		+13.41%	+82.99%

03-21	MediWound Ltd. Provides Revenue Guidance for the Year 2025 and 2026	CI
03-21	Transcript : MediWound Ltd., Q4 2023 Earnings Call, Mar 21, 2024

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

MediWound Ltd. Provides Revenue Guidance for the Year 2025 and 2026	03-21
MediWound Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	03-21
MediWound Ltd. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	03-21
Sector Update: Health Care Stocks Mixed Late Afternoon	02-12
MediWound Shares Rise After Positive Results From EscharEx Comparison Study	02-12
Mediwound Ltd. Announces Positive Results in Head-To-Head Comparison of Escharex® Vs. Santyl® Within the Chronex Phase Ii Randomized Controlled Study	02-12
MediWound's NexoBrid Application to Include Pediatric Patients Accepted for Review by FDA	01-09
Mediwound Announces That FDA Has Accepted for Review the Supplement to the Nexobrid BLA to Include Pediatric Patients with Severe Thermal Burns	01-09
MediWound Secures $6.7 Million in DoD Funding for Field Burn Treatment Therapy	12-28
Mediwound Ltd. Secures Additional U.S. Department of Defense Funding to Advance Nexobrid® Development for the U.S. Army	12-28
Mediwound Ltd. Announces Publication of Escharex Mechanism of Action Study Assessing Its Effects on Biofilm and Microbial Loads	12-21
MediWound Ltd. Appoints Shmulik Hess as Chief Operating Officer and Chief Commercial Officer, Effective December 1, 2023	11-21
MediWound Wins European Agency Approval for NexoBrid Expansion to All Age Groups in Deep Thermal Burn Cases	11-13
MediWound Ltd Receives Positive CHMP Opinion Recommending Approval for NexoBrid® to Treat Pediatric Patients	11-13
MediWound, PolyMedics Innovations Sign Agreement to Promote NexoBrid in Europe	11-08
MediWound Ltd. Announces Collaboration with PolyMedics Innovations for NexoBrid Distribution in Europe	11-08
MediWound Collaborates With 3M Unit on Drug Candidate EscharEx Late-Stage Study	23-10-11
MediWound Deploys Emergency Supply of NexoBrid to Help Burn Victims in Israel	23-10-09
MediWound Ltd. Deploys NexoBrid® for Emergency Supply	23-10-09
MediWound Ltd. Secures Additional U.S. Department of Defense Funding to Advance NexoBrid Development for the U.S. Army	23-09-26

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages MediWound Ltd.

Equities

MDWD

IL0011316309

Other languages

Filters